Global private equity and venture capital news and research

Posts Tagged ‘Versant Ventures’

29 May 2015

Versant Ventures leads $25m Series C investment round for NeuWave Medical

heart monitor medical healthcare Versant Ventures, a San Francisco-based healthcare investment company, was named as the lead investor in a $25m Series C investment round held by NeuWave Medical, a Madison, Wisconsin maker of medical devices.

28 April 2015

Versant agrees to sell drug discovery company Quanticel for $485m

health healthcare drugs pills medication medical Versant Ventures has agreed a $485m deal to offload cancer drug discovery company Quanticel Pharmaceuticals to Celgene Corporation.

17 February 2015

Versant, Frazier drive $30m Series B for US company Laguna Pharmaceuticals

BPL monitor Healthcare investors Versant Ventures and Frazier Healthcare have led a $30m financing round for cardia arrhythmia-focused Laguna Pharmaceuticals.

3 December 2014

Venture-backed gene therapy business Audentes nets $42.5m Series B

Audentes A string of venture capital firms have taken part in a $42.5m Series B financing round for gene therapy business Audentes Therapeutics.

5 November 2014

Bayer HealthCare earmarks $25m for Versant Ventures’ Fund V

medical-07-27065-m Healthcare and pharmaceutical conglomerate Bayer HealthCare is set to make a strategic investment of up to $25m to Versant Ventures’ fifth fund.

26 June 2014

NVCF provides $10m to support Versant’s Canadian expansion

kanada Venture capital firm Northleaf Venture Catalyst Fund has provided $10m to Versant to fund the healthcare-focused venture capital firm’s expansion in Canada.

14 May 2014

Ceterix Orthopaedics venture backers re-up through $18m financing

Bone Therapeutics A trio of venture capital firms have renewed their commitment to surgical tool maker Ceterix Orthopaedics through an $18m financing round.

24 April 2014

Versant invests $25m in Series A for gene editing business CRISPR

Versant Ventures has led a $25m Series A financing round for biopharmaceutical business CRISPR Therapeutics, which is currently working on a breakthrough gene editing technology.

17 April 2014

H.I.G. BioVentures leads $15m VC round for ForSight VISION5

ForSight VISION5 has closed a $15m Series C round led by H.I.G. BioVentures, alongside returning investors Morgenthaler Ventures, Versant Ventures, Technology Partners, and Delphi Ventures.

15 April 2014

Gene therapy specialist AAVLife raises $12m in Versant-led Series A

heart_lrg Life sciences-focused venture capital firm Versant Ventures has led a $12m Series A round for gene therapy specialist AAVLife.

Page 1 of 3123

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2015